Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements

Autor: Resnier, Pauline, Lepeltier, Elise, Emina, Anthea, Galopin, Natacha, Bejaud, Jérôme, David, Stéphanie, Ballet, Caroline, Benvegnu, Thierry, Pecorari, Frédéric, Chourpa, Igor, Benoit, Jean-Pierre, Passirani, Catherine

Publikováno v: RSC Advances
RSC Advances, Royal Society of Chemistry, 2019, 9 (47), pp.27264-27278. ⟨10.1039/c9ra03668g⟩
RSC Advances, 2019, 9 (47), pp.27264-27278. ⟨10.1039/c9ra03668g⟩

International audience; Malignant melanoma is an aggressive tumor, associated with the presence of local and/or distant metastases. The development of gene therapy by the use of small interfering RNA (siRNA) represents a promising new treatment. Howe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f1ce548edca76443ece840e29b21e411
https://www.hal.inserm.fr/inserm-02337070/file/Pecorari2019Eq13.pdf

Co-delivery of siRNA and ferrocifen-based drugs by lipid nanocapsules for melanoma treatment

Autor: Resnier, Pauline, Galopin, Natacha, Briganti, Alessandro, Vessières, Anne, Jaouen, Gérard, Benoit, Jean-Pierre, Passirani-Malleret, Catherine

Publikováno v: 2nd International Meeting on Translational Nanomedicines
2nd International Meeting on Translational Nanomedicines, 2014, Angers, France. 2014

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::596c30e3a03abd07f388b3ecc743179e
https://hal.univ-angers.fr/hal-03184067

Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements.

Autor: Resnier P; MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire Angers France catherine.passirani@univ-angers.fr., Lepeltier E; MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire Angers France catherine.passirani@univ-angers.fr., Emina AL; MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire Angers France catherine.passirani@univ-angers.fr., Galopin N; CRCINA, INSERM, Université d'Angers, Université de Nantes Nantes France., Bejaud J; MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire Angers France catherine.passirani@univ-angers.fr., David S; EA6295 - Nanomédicaments et Nanosondes, Université François-Rabelais de Tours, UFR de Pharmacie 31 avenue Monge F-37200 Tours France., Ballet C; Univ Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, ISCR-UMR 6226 F-35000 Rennes France., Benvegnu T; Univ Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, ISCR-UMR 6226 F-35000 Rennes France., Pecorari F; UMR CNRS 6299 - INSERM U892, CRCNA F-44007 Nantes France., Chourpa I; EA6295 - Nanomédicaments et Nanosondes, Université François-Rabelais de Tours, UFR de Pharmacie 31 avenue Monge F-37200 Tours France., Benoit JP; MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire Angers France catherine.passirani@univ-angers.fr., Passirani C; MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire Angers France catherine.passirani@univ-angers.fr.

Publikováno v: RSC advances [RSC Adv] 2019 Aug 30; Vol. 9 (47), pp. 27264-27278. Date of Electronic Publication: 2019 Aug 30 (Print Publication: 2019).